- Home
- ALNY vs DAL Comparison
ALNY vs DAL Comparison
Compare ALNY & DAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- DAL
- Stock Information
- Founded
- ALNY 2002
- DAL 1924
- Country
- ALNY United States
- DAL United States
- Employees
- ALNY N/A
- DAL N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- DAL Air Freight/Delivery Services
- Sector
- ALNY Health Care
- DAL Consumer Discretionary
- Exchange
- ALNY Nasdaq
- DAL Nasdaq
- Market Cap
- ALNY 42.9B
- DAL 34.7B
- IPO Year
- ALNY 2004
- DAL N/A
- Fundamental
- Price
- ALNY $458.28
- DAL $60.53
- Analyst Decision
- ALNY Strong Buy
- DAL Strong Buy
- Analyst Count
- ALNY 27
- DAL 13
- Target Price
- ALNY $401.92
- DAL $67.69
- AVG Volume (30 Days)
- ALNY 1.3M
- DAL 7.5M
- Earning Date
- ALNY 07-31-2025
- DAL 10-09-2025
- Dividend Yield
- ALNY N/A
- DAL 1.24%
- EPS Growth
- ALNY N/A
- DAL N/A
- EPS
- ALNY N/A
- DAL 6.88
- Revenue
- ALNY $2,461,963,000.00
- DAL $61,925,000,000.00
- Revenue This Year
- ALNY $33.75
- DAL N/A
- Revenue Next Year
- ALNY $31.66
- DAL $5.89
- P/E Ratio
- ALNY N/A
- DAL $8.80
- Revenue Growth
- ALNY 5.01
- DAL 3.01
- 52 Week Low
- ALNY $205.87
- DAL $34.74
- 52 Week High
- ALNY $462.88
- DAL $69.98
- Technical
- Relative Strength Index (RSI)
- ALNY 85.86
- DAL 68.51
- Support Level
- ALNY $421.81
- DAL $52.88
- Resistance Level
- ALNY $445.20
- DAL $59.52
- Average True Range (ATR)
- ALNY 17.25
- DAL 1.57
- MACD
- ALNY 3.15
- DAL 0.63
- Stochastic Oscillator
- ALNY 95.92
- DAL 89.24
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About DAL Delta Air Lines Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.